Candida tropicalis Nucleic Acid Detection Kit (EPIA)

Certificate

CE

Epidemiology

Candida species represent the predominant normal fungal flora in humans, commonly inhabiting the respiratory, digestive, and genitourinary tracts, as well as other environmentally exposed sites. They are typically non-pathogenic and are classified as opportunistic pathogens. Disruption of the normal microbial balance—often due to extensive use of immunosuppressive agents, tumor radiotherapy and chemotherapy, invasive procedures, organ transplantation, and broad-spectrum antibiotics—can result in Candida infections of the genital and respiratory tracts.

Genitourinary Candida infections can lead to vulvovaginitis in women and balanitis, posthitis, and prostatitis in men, severely impacting patients' lives and daily activities. The incidence of genital tract candidiasis continues to rise each year. Women account for approximately 36% of cases, men about 9%, and Candida albicans (CA) is responsible for roughly 80% of these infections.

Candida albicans infection is a major cause of mortality from nosocomial infections. Among ICU patients, C. albicans accounts for about 40% of cases. Pulmonary fungal infections are the most frequent among all deep fungal infections, with rates increasing annually. Early diagnosis and identification of pulmonary fungal infections hold critical clinical value.

Clinically reported genotypes of Candida albicans primarily include types A, B, and C, which together account for more than 90% of cases. Accurate diagnosis of Candida albicans infection informs the management of vulvovaginal candidiasis, male balanitis, posthitis, prostatitis, and respiratory tract infections caused by this organism.